Cargando…
Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative
Bone metastasis is a major cause of prostate cancer (PCa) morbidity and mortality. Despite some success in transiently controlling clinical symptoms with docetaxel-based therapy, PCa patients become docetaxel-resistant and inevitably progress with no cure. We synthesized an acyl-tyrosine bisphosphon...
Autores principales: | Zhang, Shumin, Gera, Lajos, Mamouni, Kenza, Li, Xin, Chen, Zhengjia, Kucuk, Omer, Wu, Daqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053666/ https://www.ncbi.nlm.nih.gov/pubmed/27050371 http://dx.doi.org/10.18632/oncotarget.8481 |
Ejemplares similares
-
Overcoming prostate cancer drug resistance with a novel organosilicon small molecule
por: Zhao, Rui, et al.
Publicado: (2021) -
Orbital Inflammation Caused by Aminobisphosphonates
por: Gonzalez Barlatay, J, et al.
Publicado: (2022) -
Synthetic Procedures Leading towards Aminobisphosphonates
por: Chmielewska, Ewa, et al.
Publicado: (2016) -
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
por: Li, Xin, et al.
Publicado: (2021) -
A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models()()
por: Mamouni, Kenza, et al.
Publicado: (2018)